BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:apraglutide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of apraglutide\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05018286-10886@assetmemo.bio
DTSTAMP:20261121T004039Z
DTSTART;VALUE=DATE:20271030
DTEND;VALUE=DATE:20271031
SUMMARY:apraglutide: Phase 3 readout est. (NCT05018286)
DESCRIPTION:apraglutide\, phase 3\, Short Bowel Syndrome.\nStudy: Open-labe
 l Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short
  Bowel Syndrome.\nEstimated primary completion: 30 October 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/apraglutide#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT05018286
URL:https://assetmemo.bio/drug/apraglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07742735-10886@assetmemo.bio
DTSTAMP:20261121T004039Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:apraglutide: Phase 3 readout est. (NCT07742735)
DESCRIPTION:apraglutide\, phase 3\, Short Bowel Syndrome.\nStudy: A Study t
 o Investigate the Efficacy and Safety of Apraglutide Compared With Placebo
  in Adult Participants With Short Bowel Syndrome Associated With Intestina
 l Failure (SBS-IF)\nEstimated primary completion: October 2028. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/apraglutide#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07742735
URL:https://assetmemo.bio/drug/apraglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
